Compare ABCL & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABCL | AVNS |
|---|---|---|
| Founded | 2012 | 2014 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.2B |
| IPO Year | 2020 | 2014 |
| Metric | ABCL | AVNS |
|---|---|---|
| Price | $5.97 | $24.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $8.40 | N/A |
| AVG Volume (30 Days) | ★ 6.2M | 1.2M |
| Earning Date | 05-11-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 10.91 | ★ 81.59 |
| EPS | N/A | ★ 0.11 |
| Revenue | $75,128,000.00 | ★ $701,200,000.00 |
| Revenue This Year | N/A | $3.28 |
| Revenue Next Year | $21.85 | $4.23 |
| P/E Ratio | ★ N/A | $226.82 |
| Revenue Growth | ★ 160.56 | 1.95 |
| 52 Week Low | $2.75 | $9.30 |
| 52 Week High | $6.79 | $25.49 |
| Indicator | ABCL | AVNS |
|---|---|---|
| Relative Strength Index (RSI) | 60.46 | 66.44 |
| Support Level | $5.23 | $24.64 |
| Resistance Level | $6.65 | $24.91 |
| Average True Range (ATR) | 0.52 | 0.08 |
| MACD | -0.01 | -0.12 |
| Stochastic Oscillator | 56.38 | 10.87 |
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.
Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.